NeftalyApp Courses Partner Invest Corporate Charity Divisions

Neftaly Email: sayprobiz@gmail.com Call/WhatsApp: + 27 84 313 7407

Tag: disorders

Neftaly Email: sayprobiz@gmail.com Call/WhatsApp: + 27 84 313 7407

[Contact Neftaly] [About Neftaly][Services] [Recruit] [Agri] [Apply] [Login] [Courses] [Corporate Training] [Study] [School] [Sell Courses] [Career Guidance] [Training Material[ListBusiness/NPO/Govt] [Shop] [Volunteer] [Internships[Jobs] [Tenders] [Funding] [Learnerships] [Bursary] [Freelancers] [Sell] [Camps] [Events&Catering] [Research] [Laboratory] [Sponsor] [Machines] [Partner] [Advertise]  [Influencers] [Publish] [Write ] [Invest ] [Franchise] [Staff] [CharityNPO] [Donate] [Give] [Clinic/Hospital] [Competitions] [Travel] [Idea/Support] [Events] [Classified] [Groups] [Pages]

  • Neftaly Sleep disorders identified in hospitalized patients

    Neftaly Sleep disorders identified in hospitalized patients

    Neftaly: Sleep Disorders Identified in Hospitalized Patients

    1. Overview & Significance

    Sleep disruptions are widespread among hospitalized individuals—and often overlooked. They manifest as new-onset insomnia, exacerbation of existing sleep disorders, or previously undiagnosed conditions like obstructive sleep apnea (OSA). These disruptions are driven by a mix of medical, environmental, and psychological factors and are closely tied to poor patient satisfaction and potential clinical consequences.


    2. Prevalence of Sleep Disturbances

    • Insomnia in general medical wards:
      • About 36% of hospitalized patients develop new-onset insomnia during their stay. Most cases are mild, but disruption noticeably lowers patient satisfaction—though length of stay isn’t materially impacted PMCPubMed.
      • Among elderly inpatients, around 36–37% report insomnia, strongly associated with greater illness severity, comorbidities, pain, and impaired functional independence PubMedRedalyc.org.
    • Broader hospital-wide sleep deprivation:
      • Between 33% and 69% of patients report inadequate sleep during hospitalization, often triggered by the unfamiliar environment, interruptions, noise, lighting, and discomfort NCBI.
    • Psychiatric inpatient settings:
      • Insomnia afflicts 67% of hospitalized psychiatric patients. Notably, 14% also show Restless Legs Syndrome (RLS), with severity strongly linked to anxiety, depression, and certain psychotropic medications PubMed.

    3. Common Culprits & Contributing Risk Factors

    • Hospital routines and environmental interruptions:
      • Frequent awakenings—largely due to nursing checks for vitals or blood draws—are reported in about 66–68% of insomnia cases. Illness symptoms (62%), ambient noise/lighting (22%), and stress/anxiety further compound sleep disruptions PMCPubMed.
    • Intrinsic factors—age, comorbidity, medications:
      • Older patients, especially those with pre-existing conditions like stroke, heartburn, pain, or functional limitations, have higher insomnia risk. Stroke, heartburn, and pain stand out as independent predictors PubMed.
      • Broader hospital populations show higher sleep disruption tied to chronic illnesses, psychotropic or sedative medications, endocrine and pulmonary disease, and acute or ICU-level illness PMCRedalyc.org.
    • Undiagnosed Sleep Apnea (OSA):
      • OSA affects ~25% of adults in general, yet up to 90% remain undetected—a gap likely magnified in hospitalized populations, especially those with heart failure or respiratory disease NCBI.
      • However, routine inpatient sleep screening is uncommon and sleep histories are often not documented NCBI.

    4. Consequences of In-Hospital Sleep Disruption

    • Patient experience and satisfaction:
      • Sleep disturbance during hospitalization correlates with lower patient satisfaction scores and contributes to stress and perceived care inadequacy PMCPubMed.
    • Clinical and functional impact (especially in elderly):
      • Poor sleep is associated with higher fall risk, delirium, impaired cognition, diminished functional ability, and worse nutritional status among older inpatients Redalyc.orgPubMed.
    • Post-discharge trajectory:
      • Encouragingly, up to 75% of patients with new insomnia report resolution within two weeks of discharge, according to follow-up assessments PMC.

    5. Strategies & Recommendations for Improvement

    Intervention CategoryKey Strategies
    Environmental & Routine ChangesReduce overnight disturbances (e.g., consolidate vitals checks), control noise and lighting, provide sleep aids like eye masks and earplugs. A JAMA Network Open study showed quiet wards rose from 51% to 86% after these reforms Axios.
    Screening & Risk IdentificationImplement brief sleep assessments (e.g., ISI or AIS), with focus on elderly or psychiatric patients. Use screening tools for OSA (e.g., Berlin Questionnaire) where feasible.
    Non-Pharmacological Sleep SupportPrioritize interventions like sleep hygiene education, modifying care schedules, and environmental adjustments before resorting to medications NCBIRedalyc.org.
    Targeted Medication UseAvoid sedative-hypnotics in elderly due to fall, delirium, or cognitive risk. Review evening dosing of medications like beta-blockers, SSRIs, and diuretics that may impair sleep Redalyc.orgPMC.
    Post-Discharge Follow-UpMonitor patients with new inpatient insomnia post-discharge, as many cases resolve but some may persist—potentially requiring outpatient sleep referral.

    6. Summary Table: Key Insights

    AspectFindings
    Prevalence (general wards)~36% new-onset insomnia; up to 69% report poor sleep overall
    Elderly patients36–37% experience insomnia; linked to disease burden and functional impairment
    Psychiatric inpatients67% report insomnia; 14% RLS; tied to mood symptoms and meds
    Common causesStaff interruptions, illness symptoms, environmental disturbance
    OSA riskLikely elevated and largely undiagnosed in hospital settings
    Post-discharge recovery~75% insomnia resolution in two weeks
    Intervention impactImproving ward quietness significantly boosts sleep perception

    7. Conclusion

    Sleep disorders—especially insomnia—are highly prevalent among hospitalized patients and arise from a blend of environmental factors, clinical conditions, and insufficient care structures. Beyond discomfort, these disorders erode satisfaction, increase fall risks, and potentially worsen recovery, especially in older patients.

    Actionable steps—like modifying ward routines, screening at-risk groups, prioritizing non-pharmacological sleep support, and cautious prescribing—can dramatically improve in-hospital rest, patient outcomes, and post-discharge recovery.

  • Neftaly Neurocognitive disorders and adverse event rates

    Neftaly Neurocognitive disorders and adverse event rates

    Neftaly: Neurocognitive Disorders and Adverse Event Rates

    1. Introduction & Significance

    Neurocognitive disorders—especially dementia and delirium—are common among hospitalized adults and significantly increase the risk of adverse events (AEs) such as falls, infections, drug-related complications, extended stays, readmissions, and mortality. Understanding these associations is crucial for improving inpatient care and safety.


    2. Adverse Events in Patients with Dementia

    • A recent scoping review (2023) found that patients with dementia endure significantly more adverse in-hospital events—including falls, delirium, and infections—than those without dementia. While direct causal links remain exploratory, these events are consistently associated with longer hospital stays, higher mortality, and increased 90-day readmission rates.PubMed
    • Regarding adverse drug reactions (ADRs):
      • In Tasmania, ADR-related admissions in dementia patients were marked by higher in-hospital mortality (HR ≈ 1.40) and escalated mortality at 30, 60, and 90 days post-admission. These patients were also 9–10 times more likely to be re-admitted for ADRs within 90 days.PubMed
      • A Sydney cohort study of patients aged ≥75 found that ADRs were less frequently detected in those with dementia (8.3%) compared to those without (14.6%), signaling likely under-detection in dementia patients.PMC

    3. Delirium: Frequency & Consequences

    • Prevalence: Delirium occurs in 18–35% of hospitalized patients and may develop during the hospital stay, especially among older individuals with predisposing factors such as existing cognitive impairment.Wikipedia+1
    • Outcomes:
      • Occurrence of delirium doubles the risk of in-hospital mortality and increases post-discharge functional dependence, institutionalization, and even accelerates cognitive decline toward dementia.Wikipedia

    4. Post-ICU Cognitive Impairment (PICS)

    • Survivors of critical illness frequently develop persistent cognitive deficits—affecting memory, attention, and executive functions—in up to 80% of cases.Wikipedia
    • These impairments stem from factors like delirium, sepsis, respiratory failure, and brain inflammation. They commonly translate into prolonged functional difficulties, such as unemployment and challenges with daily tasks.Wikipedia

    5. Postoperative Neurocognitive Disorders (ePND)

    • Among surgical patients, the rate of early postoperative neurocognitive disorders (ePND) is approximately 13%. While overall mortality in these cases is relatively low (~1.4%), the presence of cognitive complications—especially delirium—still poses important risks and can influence recovery trajectories.PMC

    6. Impact on Hospital Outcomes & Safety

    • A Portuguese study of elderly inpatients revealed that those who experienced adverse events during hospitalization—such as falls or infections—had significantly higher rates of death. Specifically, 69.6% of patients who died had an adverse event, compared to 47.8% who survived.NCBI

    7. Summary Table: Neurocognitive Disorders & Adverse Event Burden

    Neurocognitive ConditionAdverse Event Risks & Outcomes
    DementiaHigher rates of falls, delirium, infections; longer stays, greater mortality/readmissions; ADR-related mortality ↑; ADRs often under-detected
    DeliriumOccurs in ~18–35% of hospitalized patients; doubles mortality risk; increases functional decline, institutionalization, and dementia risk
    Post-ICU Cognitive Impairment (PICS)Up to 80% of ICU survivors have lasting cognitive deficits; impairs memory, attention, executive function; hinders daily functioning
    Postoperative Neurocognitive Disorder (ePND)Occurs in ~13% of surgical patients; mortality ~1.4%; may undermine recovery and rehabilitation

    8. Key Implications & Recommendations

    A. Screen Early and Frequently

    • Integrate routine delirium screening (e.g., CAM, 4AT) on admission and regularly thereafter—especially in older patients or those with cognitive impairment.

    B. Proactive ADR Monitoring

    • Implement pharmacist-led medication reviews and improve detection methods to counter ADR under-recognition in dementia patients.

    C. Delirium Prevention Protocols

    • Use multimodal strategies like the HELP model—involving mobility support, hydration, sleep hygiene, and sensory aids—to reduce delirium risk. Up to 30–40% of delirium cases may be preventable.Wikipedia

    D. PICS Prevention & Rehabilitation

    • In ICU settings, minimize sedation, prioritize early mobilization, and assess cognition at follow-up to identify emerging PICS.

    E. Rehabilitative Planning

    • After surgery, monitor for cognitive changes and offer tailored rehab plans for patients exhibiting ePND.

    F. Supportive Transitions

    • For dementia patients, secure early discharge planning and ensure adequate social support, which correlates with shorter psychiatric stays.PubMed

    9. Conclusion

    Neurocognitive disorders such as dementia, delirium, PICS, and postoperative cognitive decline substantially heighten the risk of adverse events and worsen inpatient outcomes. To counter this, healthcare systems must prioritize early detection, multidisciplinary prevention strategies, tailored rehabilitation, and robust support systems to enhance safety, functional outcomes, and overall quality of care.

  • Neftaly Clinical management of chronic inflammatory disorders

    Neftaly Clinical management of chronic inflammatory disorders

    Clinical Management of Chronic Inflammatory Disorders

    Introduction

    Chronic inflammatory disorders, such as rheumatoid arthritis, inflammatory bowel disease, psoriasis, and lupus, affect millions worldwide, often resulting in persistent symptoms, tissue damage, and impaired quality of life. Effective clinical management is essential to control inflammation, prevent complications, and improve patient outcomes.

    At Neftaly, we emphasize evidence-based approaches and multidisciplinary care strategies that enable clinicians to navigate the complexities of chronic inflammation with precision and compassion.


    Understanding Chronic Inflammatory Disorders

    Chronic inflammatory disorders are characterized by prolonged and dysregulated immune responses that target the body’s own tissues. This sustained inflammation can lead to progressive organ damage, disability, and systemic complications.

    Successful management hinges on early diagnosis, ongoing monitoring, and individualized treatment plans tailored to disease activity, comorbidities, and patient preferences.


    Core Principles of Clinical Management

    1. Accurate Diagnosis and Disease Activity Assessment

    • Utilize clinical evaluation, laboratory markers (e.g., CRP, ESR), and imaging studies to establish diagnosis and assess severity.
    • Employ validated disease activity scores (e.g., DAS28 for rheumatoid arthritis, Mayo score for ulcerative colitis) for objective monitoring.
    • Regular assessment enables timely adjustment of therapy to achieve disease remission or low activity.

    2. Pharmacologic Therapy

    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and corticosteroids provide symptomatic relief and control acute flares.
    • Disease-Modifying Anti-Rheumatic Drugs (DMARDs) such as methotrexate or sulfasalazine are cornerstone treatments that slow disease progression.
    • Biologic agents targeting specific immune pathways (e.g., TNF inhibitors, IL-6 receptor blockers) offer powerful options for refractory or severe cases.
    • Personalized medication regimens balance efficacy with safety, minimizing adverse effects.

    3. Lifestyle and Supportive Measures

    • Encourage smoking cessation, balanced nutrition, and regular physical activity to reduce inflammation and improve overall health.
    • Physical and occupational therapy help maintain mobility and function.
    • Psychosocial support addresses mental health challenges common in chronic illness.

    4. Multidisciplinary Care Coordination

    • Collaboration among rheumatologists, gastroenterologists, dermatologists, primary care, and allied health professionals ensures comprehensive care.
    • Patient education promotes adherence, self-management, and informed decision-making.

    5. Monitoring and Managing Comorbidities

    • Chronic inflammation predisposes patients to cardiovascular disease, osteoporosis, and infections.
    • Proactive screening and preventive care are integral to holistic management.

    Emerging Trends and Future Directions

    • Advances in biomarkers and genomics are enhancing personalized treatment strategies.
    • Novel small molecule inhibitors and cell-based therapies are expanding therapeutic options.
    • Digital health tools enable remote monitoring, patient engagement, and data-driven clinical decisions.

    Conclusion

    Effective clinical management of chronic inflammatory disorders requires a multifaceted, patient-centered approach that integrates the latest scientific advances with compassionate care. By prioritizing early intervention, tailored therapies, and continuous support, healthcare providers can significantly improve patient outcomes and quality of life.

    At Neftaly, we are dedicated to empowering clinicians with the knowledge and tools necessary to deliver exemplary care in the evolving landscape of chronic inflammatory diseases.